Worldwide Clinical Trials Experts to Present at Adriatic Neurology Forum

Tomislav Babic M.D., Ph.D., and Miroslav Backonja, M.D., to discuss disease-modifying drug development in Alzheimer’s disease and central neuropathic pain in MS and NMO

MORRISVILLE, N.C.--()--Two leading central nervous system (CNS) experts from Worldwide Clinical Trials (www.worldwide.com) will present at the 6th Adriatic Neurology Forum (ANF), being held 3-7 May in Opatija, Croatia.

Tomislav Babic, M.D., Ph.D., Vice President of Neuroscience, who also supported the organization of this year’s ANF sessions, will discuss “Disease Modifying Drug Development in Alzheimer’s Disease” on Friday, 5 May at 9:50 a.m. CEST. Dr. Babic will cover diagnostic and methodological challenges in early and preclinical Alzheimer’s disease.

On Saturday, 6 May at 11:25 a.m. CEST, Miroslav Backonja, M.D., Senior Medical Director of Neuroscience, will make a presentation titled “Central Neuropathic Pain in Multiple Sclerosis (MS) and Neuromyelitis Optica (NMO).” Dr. Backonja will review clinical presentations of central neuropathic pain in MS and NMO, and the role of central pain mechanisms.

“Over the course of the forum, attendees will hear from speakers on a wide range of topics. In our sessions, Dr. Backonja and I will be touching on the pharmacotherapy and non-pharmacological approaches to the treatment of neuropathic pain, failures in Alzheimer’s disease clinical research, and our personal recommendations for study designs,” commented Dr. Babic. “The ANF has become a traditional gathering of leading neurologists and neuroscientists from across the globe, and is a fantastic platform for both leading experts in the field and newcomers to meet, learn and network.”

The ANF is a joint annual conference of Croatian and Serbian neurologists, dedicated to discussing and exploring emerging trends in the fields of epilepsy, MS and neurodegenerative diseases. Attendees will benefit from scientific exchange during the formal activities and informal meetings with colleagues, with the chance to hear talks from experts from across the world.

To register for this event and to find out more information, please visit www.neuronet.hr.

Connect with Worldwide Clinical Trials:

About Worldwide Clinical Trials

Worldwide Clinical Trials employs more than 1,400 professionals around the world, with offices in North and South America, Eastern and Western Europe, Russia and Asia. One of the world’s leading, full-service contract research organizations (CROs), we partner with sponsors in the pharmaceutical and biotechnology industries to deliver fully integrated clinical development and bioanalytical services, extending from first-in-human through phase IV studies. Grounded in medicine and science, we help sponsors move from discovery into clinical development and commercialization across a range of therapeutic areas, including neuroscience, cardiovascular diseases, immune-mediated inflammatory disorders (IMID), and rare diseases. For more information, visit worldwide.com.

Contacts

Worldwide Clinical Trials
LuJean Smith, 610-329-2056
lujean.smith@worldwide.com

Contacts

Worldwide Clinical Trials
LuJean Smith, 610-329-2056
lujean.smith@worldwide.com